ARG1 and neoplasm: Other tumor EV-driven mechanisms of immunosuppression involve enhanced proliferation and expansion of immunosuppressive Treg cells while impairing proliferation and inducing cytokine release and exhaustion of effector T-cells through the delivery of regulatory miRNAs and enzymatically active arginase-1 (ARG1), as detailed elsewhere [46,53].